Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 706

1.

Feasibility of subtotal esophagectomy with systematic lymphadenectomy in selected elderly patients with esophageal cancer; a propensity score matching analysis.

Kanda M, Koike M, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Omae K, Kodera Y.

BMC Surg. 2019 Oct 15;19(1):143. doi: 10.1186/s12893-019-0617-2.

2.

Modified Systemic Inflammation Score is Useful for Risk Stratification After Radical Resection of Squamous Cell Carcinoma of the Esophagus.

Kanda M, Koike M, Tanaka C, Kobayashi D, Hattori N, Hayashi M, Yamada S, Omae K, Fujiwara M, Kodera Y.

Ann Surg Oncol. 2019 Oct 11. doi: 10.1245/s10434-019-07914-7. [Epub ahead of print]

PMID:
31605344
3.

Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer.

Umeda S, Kanda M, Miwa T, Tanaka H, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y.

Int J Cancer. 2019 Oct 9. doi: 10.1002/ijc.32705. [Epub ahead of print]

PMID:
31597194
4.

Metabolism of fatty acids and bile acids in plasma is associated with overactive bladder in males: potential biomarkers and targets for novel treatments in a metabolomics analysis.

Mitsui T, Kira S, Ihara T, Sawada N, Nakagomi H, Miyamoto T, Shimura H, Tsuchiya S, Kanda M, Takeda M.

Int Urol Nephrol. 2019 Oct 5. doi: 10.1007/s11255-019-02299-8. [Epub ahead of print]

PMID:
31587188
5.

Tumor size  ≥50 mm as an Independent Prognostic Factor for Patients with Stage II or III Gastric Cancer After Postoperative S-1 Monotherapy: Analysis of a Multi-institution Dataset.

Tsutsuyama M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

World J Surg. 2019 Sep 24. doi: 10.1007/s00268-019-05198-2. [Epub ahead of print]

PMID:
31552460
6.

Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II).

Hattori N, Nakayama G, Uehara K, Aiba T, Ishigure K, Sakamoto E, Tojima Y, Kanda M, Kobayashi D, Tanaka C, Yamada S, Koike M, Fujiwara M, Nagino M, Kodera Y.

Int J Clin Oncol. 2019 Sep 21. doi: 10.1007/s10147-019-01546-3. [Epub ahead of print]

PMID:
31542847
7.

Preoperative predictors of postoperative complications after gastric cancer resection.

Kanda M.

Surg Today. 2019 Sep 18. doi: 10.1007/s00595-019-01877-8. [Epub ahead of print] Review.

PMID:
31535226
8.

Prognosis After Laparoscopic Gastrectomy in Patients with Pathological Stage II or III Gastric Cancer Who Were Preoperatively Diagnosed with Clinical Stage I: Propensity Score Matching Analysis of a Multicenter Dataset.

Ito Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Ann Surg Oncol. 2019 Sep 6. doi: 10.1245/s10434-019-07781-2. [Epub ahead of print]

PMID:
31493125
9.

Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis.

Kobayashi D, Ishigami H, Kanda M, Tanaka C, Yamaguchi H, Kitayama J, Kodera Y.

Oncology. 2019 Sep 5:1-5. doi: 10.1159/000502484. [Epub ahead of print]

PMID:
31487733
10.

Incorporating molecular biomarkers into clinical practice for gastric cancer.

Nakamura S, Kanda M, Kodera Y.

Expert Rev Anticancer Ther. 2019 Sep;19(9):757-771. doi: 10.1080/14737140.2019.1659136. Epub 2019 Aug 26.

PMID:
31437076
11.

Low-dose perampanel improves refractory cortical myoclonus by the dispersed and suppressed paroxysmal depolarization shifts in the sensorimotor cortex.

Oi K, Neshige S, Hitomi T, Kobayashi K, Tojima M, Matsuhashi M, Shimotake A, Fujii D, Matsumoto R, Kasama S, Kanda M, Wada Y, Maruyama H, Takahashi R, Ikeda A.

Clin Neurophysiol. 2019 Oct;130(10):1804-1812. doi: 10.1016/j.clinph.2019.07.006. Epub 2019 Jul 19.

PMID:
31401489
12.

[Determination of Antifungal Drugs in Fish and Livestock Products Using LC-MS/MS].

Nakagawa Y, Kanda M, Hayashi H, Matsushima Y, Ohba Y, Koike H, Nagano C, Sekimura K, Otsuka K, Sasamoto T, Hashimoto T.

Shokuhin Eiseigaku Zasshi. 2019;60(3):52-60. doi: 10.3358/shokueishi.60.52. Japanese.

13.

Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study.

Kanda M, Suh YS, Park DJ, Tanaka C, Ahn SH, Kong SH, Lee HJ, Kobayashi D, Fujiwara M, Shimada H, Cho B, Murotani K, Kim HH, Yang HK, Kodera Y.

Gastric Cancer. 2019 Aug 3. doi: 10.1007/s10120-019-00995-z. [Epub ahead of print]

PMID:
31377880
14.

Multi-institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer.

Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Cancer Med. 2019 Sep;8(11):5194-5201. doi: 10.1002/cam4.2439. Epub 2019 Jul 29.

15.

Dicyemid Mesozoans: A Unique Parasitic Lifestyle and a Reduced Genome.

Lu TM, Kanda M, Furuya H, Satoh N.

Genome Biol Evol. 2019 Aug 1;11(8):2232-2243. doi: 10.1093/gbe/evz157.

16.

Intermittent restraint stress induces circadian misalignment in the mouse bladder, leading to nocturia.

Ihara T, Nakamura Y, Mitsui T, Tsuchiya S, Kanda M, Kira S, Nakagomi H, Sawada N, Kamiyama M, Shigetomi E, Shinozaki Y, Yoshiyama M, Nakao A, Koizumi S, Takeda M.

Sci Rep. 2019 Jul 11;9(1):10069. doi: 10.1038/s41598-019-46517-w.

17.

Comparison of non-invasive liver reserve and fibrosis models: Implications for surgery and prognosis for hepatocellular carcinoma.

Sonohara F, Yamada S, Tanaka N, Tashiro M, Sunagawa Y, Morimoto D, Tanaka H, Takami H, Hayashi M, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y.

Hepatol Res. 2019 Jul 1. doi: 10.1111/hepr.13400. [Epub ahead of print]

PMID:
31260575
18.

Recent advances in molecular biomarkers for patients with hepatocellular carcinoma.

Umeda S, Kanda M, Kodera Y.

Expert Rev Mol Diagn. 2019 Aug;19(8):725-738. doi: 10.1080/14737159.2019.1638254. Epub 2019 Jul 3.

PMID:
31248309
19.

Albumin-Bilirubin Score Predicts Tolerability to Adjuvant S-1 Monotherapy after Curative Gastrectomy.

Miwa T, Kanda M, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y.

J Gastric Cancer. 2019 Jun;19(2):183-192. doi: 10.5230/jgc.2019.19.e15. Epub 2019 Apr 22.

20.

Long-lasting discussion: Adverse effects of intraoperative blood loss and allogeneic transfusion on prognosis of patients with gastric cancer.

Nakanishi K, Kanda M, Kodera Y.

World J Gastroenterol. 2019 Jun 14;25(22):2743-2751. doi: 10.3748/wjg.v25.i22.2743. Review.

21.

Analysing public sector institutional capacity for health workforce governance in the South-East Asia region of WHO.

Cometto G, Nartey E, Zapata T, Kanda M, Md Y, Narayan K, Pritasari K, Irufa A, Lamichhane R, De Silva D, Noree T.

Hum Resour Health. 2019 Jun 18;17(1):43. doi: 10.1186/s12960-019-0385-1.

22.

Risk Prediction of Postoperative Pneumonia After Subtotal Esophagectomy Based on Preoperative Serum Cholinesterase Concentrations.

Kanda M, Koike M, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Omae K, Kodera Y.

Ann Surg Oncol. 2019 Oct;26(11):3718-3726. doi: 10.1245/s10434-019-07512-7. Epub 2019 Jun 13.

PMID:
31197518
23.

The Translational Landscape of the Human Heart.

van Heesch S, Witte F, Schneider-Lunitz V, Schulz JF, Adami E, Faber AB, Kirchner M, Maatz H, Blachut S, Sandmann CL, Kanda M, Worth CL, Schafer S, Calviello L, Merriott R, Patone G, Hummel O, Wyler E, Obermayer B, Mücke MB, Lindberg EL, Trnka F, Memczak S, Schilling M, Felkin LE, Barton PJR, Quaife NM, Vanezis K, Diecke S, Mukai M, Mah N, Oh SJ, Kurtz A, Schramm C, Schwinge D, Sebode M, Harakalova M, Asselbergs FW, Vink A, de Weger RA, Viswanathan S, Widjaja AA, Gärtner-Rommel A, Milting H, Dos Remedios C, Knosalla C, Mertins P, Landthaler M, Vingron M, Linke WA, Seidman JG, Seidman CE, Rajewsky N, Ohler U, Cook SA, Hubner N.

Cell. 2019 Jun 27;178(1):242-260.e29. doi: 10.1016/j.cell.2019.05.010. Epub 2019 May 30.

PMID:
31155234
24.

Novel implications of combined arterial resection for locally advanced pancreatic cancer in the era of newer chemo-regimens.

Sonohara F, Yamada S, Takami H, Hayashi M, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y.

Eur J Surg Oncol. 2019 Oct;45(10):1895-1900. doi: 10.1016/j.ejso.2019.05.019. Epub 2019 May 22.

PMID:
31147087
25.

Continuous Compressive Force Induces Differentiation of Osteoclasts with High Levels of Inorganic Dissolution.

Matsuike R, Nakai K, Tanaka H, Ozaki M, Kanda M, Nagasaki M, Shibata C, Mayahara K, Tanabe N, Koshi R, Nakajima A, Kawato T, Maeno M, Shimizu N, Motoyoshi M.

Med Sci Monit. 2019 May 26;25:3902-3909. doi: 10.12659/MSM.913674.

26.

Preoperative six-minute walk distance as a predictor of postoperative complication in patients with esophageal cancer.

Inoue T, Ito S, Kanda M, Niwa Y, Nagaya M, Nishida Y, Hasegawa Y, Koike M, Kodera Y.

Dis Esophagus. 2019 May 20. pii: doz050. doi: 10.1093/dote/doz050. [Epub ahead of print]

PMID:
31111872
27.

Quantification of staphylococcal enterotoxin type A in cow milk by using a stable isotope-labelled peptide via liquid chromatography-tandem mass spectrometry.

Koike H, Kanda M, Hayashi H, Matsushima Y, Ohba Y, Nakagawa Y, Nagano C, Sekimura K, Hirai A, Shindo T, Otsuka K, Kamiie J, Sasamoto T, Hashimoto T.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2019 Jul;36(7):1098-1108. doi: 10.1080/19440049.2019.1615641. Epub 2019 May 16.

PMID:
31094669
28.

Detection of indocyanine green fluorescence to determine tumor location during laparoscopic gastrectomy for gastric cancer: Results of a prospective study.

Tanaka C, Kanda M, Funasaka K, Miyahara R, Murotani K, Tanaka Y, Takeda S, Kobayashi D, Hirooka Y, Fujiwara M, Goto H, Kodera Y.

Asian J Endosc Surg. 2019 May 8. doi: 10.1111/ases.12710. [Epub ahead of print]

PMID:
31070004
29.

Delivering on global health priorities: the WHO Task Force on Nursing and Midwifery.

Iro E, Odugleh-Kolev A, Bingham M, Oweis A, Kanda M, Cassiani S, McConville F, Samuelson J, Jacoby S, Moller AB; WHO Task Force on Nursing and Midwifery.

Lancet. 2019 May 4;393(10183):1784-1786. doi: 10.1016/S0140-6736(19)30842-6. No abstract available.

PMID:
31057151
30.

The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer.

Nakanishi K, Kanda M, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Kodera Y.

Gastric Cancer. 2019 May 4. doi: 10.1007/s10120-019-00967-3. [Epub ahead of print]

PMID:
31055693
31.

Publisher Correction: Medusozoan genomes inform the evolution of the jellyfish body plan.

Khalturin K, Shinzato C, Khalturina M, Hamada M, Fujie M, Koyanagi R, Kanda M, Goto H, Anton-Erxleben F, Toyokawa M, Toshino S, Satoh N.

Nat Ecol Evol. 2019 Jun;3(6):989. doi: 10.1038/s41559-019-0905-3.

PMID:
31048744
32.

ASO Author Reflections: Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival.

Miwa T, Kanda M.

Ann Surg Oncol. 2019 Apr 25. doi: 10.1245/s10434-019-07405-9. [Epub ahead of print] No abstract available.

PMID:
31025230
33.

ASO Author Reflections: Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer.

Uno Y, Kanda M.

Ann Surg Oncol. 2019 Apr 24. doi: 10.1245/s10434-019-07404-w. [Epub ahead of print] No abstract available.

PMID:
31020503
34.

High-resolution global urban growth projection based on multiple applications of the SLEUTH urban growth model.

Zhou Y, Varquez ACG, Kanda M.

Sci Data. 2019 Apr 18;6(1):34. doi: 10.1038/s41597-019-0048-z.

35.

Medusozoan genomes inform the evolution of the jellyfish body plan.

Khalturin K, Shinzato C, Khalturina M, Hamada M, Fujie M, Koyanagi R, Kanda M, Goto H, Anton-Erxleben F, Toyokawa M, Toshino S, Satoh N.

Nat Ecol Evol. 2019 May;3(5):811-822. doi: 10.1038/s41559-019-0853-y. Epub 2019 Apr 15. Erratum in: Nat Ecol Evol. 2019 Jun;3(6):989.

PMID:
30988488
36.

Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer.

Suenaga Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

World J Gastrointest Oncol. 2019 Jan 15;11(1):17-27. doi: 10.4251/wjgo.v11.i1.17.

37.

Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss.

Ohmura K, Oku K, Kitaori T, Amengual O, Hisada R, Kanda M, Shimizu Y, Fujieda Y, Kato M, Bohgaki T, Horita T, Yasuda S, Sugiura-Ogasawara M, Atsumi T.

Clin Immunol. 2019 Jun;203:37-44. doi: 10.1016/j.clim.2019.04.005. Epub 2019 Apr 8.

PMID:
30974291
38.

Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset.

Nakanishi K, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Gastric Cancer. 2019 Apr 6. doi: 10.1007/s10120-019-00961-9. [Epub ahead of print]

PMID:
30955110
39.

A draft nuclear-genome assembly of the acoel flatworm Praesagittifera naikaiensis.

Arimoto A, Hikosaka-Katayama T, Hikosaka A, Tagawa K, Inoue T, Ueki T, Yoshida MA, Kanda M, Shoguchi E, Hisata K, Satoh N.

Gigascience. 2019 Apr 1;8(4). pii: giz023. doi: 10.1093/gigascience/giz023.

40.

Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation.

Hisada R, Kato M, Sugawara E, Kanda M, Fujieda Y, Oku K, Bohgaki T, Amengual O, Horita T, Yasuda S, Atsumi T.

J Thromb Haemost. 2019 Jul;17(7):1134-1143. doi: 10.1111/jth.14427. Epub 2019 Mar 30.

PMID:
30864219
41.

The Preoperative Prognostic Nutritional Index Predicts Short-Term and Long-Term Outcomes of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-Institution Dataset.

Sasahara M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Dig Surg. 2019 Mar 6:1-10. doi: 10.1159/000497454. [Epub ahead of print]

PMID:
30840952
42.

Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer.

Kato Y, Yamada S, Tashiro M, Sonohara F, Takami H, Hayashi M, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Koike M, Fujiwara M, Kodera Y.

HPB (Oxford). 2019 Sep;21(9):1211-1218. doi: 10.1016/j.hpb.2019.01.012. Epub 2019 Feb 14.

PMID:
30773450
43.

A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer.

Izumi D, Gao F, Toden S, Sonohara F, Kanda M, Ishimoto T, Kodera Y, Wang X, Baba H, Goel A.

EBioMedicine. 2019 Mar;41:268-275. doi: 10.1016/j.ebiom.2019.01.057. Epub 2019 Feb 13.

44.

Proposal of a Scoring Scale to Estimate Risk of the Discontinuation of S-1 Adjuvant Monotherapy in Patients with Stage II to III Gastric Cancer: A Multi-Institutional Dataset Analysis.

Iizuka A, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

World J Surg. 2019 Aug;43(8):2016-2024. doi: 10.1007/s00268-019-04942-y.

PMID:
30737551
45.

Perioperative and prognostic implication of albumin-bilirubin-TNM score in Child-Pugh class A hepatocellular carcinoma.

Sonohara F, Yamada S, Tanaka N, Suenaga M, Takami H, Hayashi M, Niwa Y, Sugimoto H, Hattori N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y.

Ann Gastroenterol Surg. 2018 Sep 27;3(1):65-74. doi: 10.1002/ags3.12212. eCollection 2019 Jan.

46.

Homeobox C10 Influences on the Malignant Phenotype of Gastric Cancer Cell Lines and its Elevated Expression Positively Correlates with Recurrence and Poor Survival.

Miwa T, Kanda M, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y.

Ann Surg Oncol. 2019 May;26(5):1535-1543. doi: 10.1245/s10434-019-07166-5. Epub 2019 Jan 23.

PMID:
30673899
47.

The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting.

Obi S, Sato T, Sato S, Kanda M, Tokudome Y, Kojima Y, Suzuki Y, Hosoda K, Kawai T, Kondo Y, Isomura Y, Ohyama H, Nakagomi K, Ashizawa H, Miura Y, Amano H, Mochizuki H, Omata M.

Hepatol Int. 2019 Mar;13(2):199-204. doi: 10.1007/s12072-019-09929-4. Epub 2019 Jan 22.

PMID:
30671808
48.

Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer.

Uno Y, Kanda M, Miwa T, Umeda S, Tanaka H, Tanaka C, Kobayashi D, Suenaga M, Hattori N, Hayashi M, Yamada S, Nakayama G, Fujiwara M, Kodera Y.

Ann Surg Oncol. 2019 Mar;26(3):836-844. doi: 10.1245/s10434-018-07149-y. Epub 2019 Jan 7.

PMID:
30617870
49.

Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy.

Niwa Y, Yamada S, Sonohara F, Kurimoto K, Hayashi M, Tashiro M, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y.

J Transl Med. 2019 Jan 3;17(1):1. doi: 10.1186/s12967-018-1762-6.

50.

The Controlling Nutritional Status Score Serves as a Predictor of Short- and Long-Term Outcomes for Patients with Stage 2 or 3 Gastric Cancer: Analysis of a Multi-institutional Data Set.

Ryo S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y.

Ann Surg Oncol. 2019 Feb;26(2):456-464. doi: 10.1245/s10434-018-07121-w. Epub 2018 Dec 18.

PMID:
30565044

Supplemental Content

Support Center